Form 483

Hawknad Manufacturing Industries, Inc. Form 483, 2013-08-02

FDA issued a Form 483 to Hawknad Manufacturing Industries, Inc. on 2013-08-02 with 5 public-safe observations.

483· Form 483 issuedHuman Drugs5 observations

Hawknad Manufacturing Industries, Inc. · Alexandria, United States · Issued August 2, 2013

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

2 Aug 2013
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Collins M Mason, Susan J Essenmacher

2 Aug 2013
21 CFR 211.67(b)

Written procedures fail to include

Cited by Collins M Mason, Susan J Essenmacher

2 Aug 2013
21 CFR 211.68(a)

Calibration/Inspection/Checking not done

Cited by Collins M Mason, Susan J Essenmacher

2 Aug 2013
21 CFR 211.80(a)

Procedures To Be in Writing

Cited by Collins M Mason, Susan J Essenmacher

2 Aug 2013
21 CFR 211.84(b)

Representative Samples Criteria

Cited by Collins M Mason, Susan J Essenmacher

Inspected site

HMHawknad Manufacturing Industries, Inc.Alexandria, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x
21 CFR 211.80(a)Cited across public-safe Form 483 observations1x
21 CFR 211.84(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 5 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere